Long-Term Safety Of Facilitated Subcutaneous Immunoglobulin Treatment In Patients With Primary Immunodeficiency Diseases: Interim Analysis From A Post-Authorization Safety Study
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要